| Type |
Details |
Score |
| HT Experiment |
| Series Id: |
GSE38830 |
| Experiment Type: |
transcription profiling by array |
| Study Type: |
WT vs. Mutant |
| Source: |
ArrayExpress |
|
•
•
•
•
•
|
| UniProt Feature |
| Begin: |
354 |
| Description: |
Cleavage; by ADAM10 and ADAM17 |
| Type: |
site |
| End: |
355 |
|
•
•
•
•
•
|
| HT Experiment |
|
| Experiment Type: |
RNA-Seq |
| Study Type: |
WT vs. Mutant |
| Source: |
GEO |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tellier E |
| Year: |
2006 |
| Journal: |
Exp Cell Res |
| Title: |
The shedding activity of ADAM17 is sequestered in lipid rafts. |
| Volume: |
312 |
| Issue: |
20 |
| Pages: |
3969-80 |
|
•
•
•
•
•
|
| Interaction Experiment |
| Description: |
ADAM17 variant causes hair loss via ubiquitin ligase TRIM47-mediated degradation. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Li R |
| Year: |
2018 |
| Journal: |
J Cell Sci |
| Title: |
Regulation of profibrotic responses by ADAM17 activation in high glucose requires its C-terminus and FAK. |
| Volume: |
131 |
| Issue: |
4 |
|
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:8249286 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2025-10-03 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1754424 |
| Pattern: |
Not Specified |
| Stage: |
TS24 |
| Assay Id: |
MGI:8249335 |
| Age: |
embryonic day 16.5 |
|
| Note: |
Expression co-localized with Adam17 in cortical neurons. |
| Specimen Label: |
4E/G,H/J |
| Detected: |
true |
| Specimen Num: |
12 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lartey NL |
| Year: |
2021 |
| Journal: |
bioRxiv |
| Title: |
ADAM17 inhibition prevents neutrophilia and lung injury in a mouse model of Covid-19. |
|
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tian Y |
| Year: |
2023 |
| Journal: |
Front Mol Neurosci |
| Title: |
The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer's disease. |
| Volume: |
16 |
|
| Pages: |
1125932 |
|
•
•
•
•
•
|
| GO Term |
|
•
•
•
•
•
|
| DO Term |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Heurich A |
| Year: |
2014 |
| Journal: |
J Virol |
| Title: |
TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. |
| Volume: |
88 |
| Issue: |
2 |
| Pages: |
1293-307 |
|
•
•
•
•
•
|
| Allele |
| Name: |
a disintegrin and metallopeptidase domain 17; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
| Allele Type: |
Endonuclease-mediated |
| Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:6690292 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2021-04-12 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1697423 |
| Pattern: |
Regionally restricted |
| Stage: |
TS23 |
| Assay Id: |
MGI:6690294 |
| Age: |
embryonic day 15.5 |
| Image: |
4C |
| Note: |
Expression was detected in neurons in the substantia nigra and the ventral tegmental area and co-localized with Adam17 immunostaining. |
| Specimen Label: |
4C |
| Detected: |
true |
| Specimen Num: |
2 |
|
•
•
•
•
•
|
| GXD Expression |
| Probe: |
MGI:3580797 |
| Assay Type: |
Immunohistochemistry |
| Annotation Date: |
2005-07-06 |
| Strength: |
Present |
| Sex: |
Not Specified |
| Emaps: |
EMAPS:1750328 |
| Pattern: |
Regionally restricted |
| Stage: |
TS28 |
| Assay Id: |
MGI:3580832 |
| Age: |
postnatal adult |
| Image: |
5H, 5I |
| Note: |
Expression was detected in the cell membrane. Expression did not colocalize with Adam17 in the cell membranes of the islets of Langerhans. |
| Specimen Label: |
5H, 5I |
| Detected: |
true |
| Specimen Num: |
3 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
D?sterh?ft S |
| Year: |
2013 |
| Journal: |
J Am Chem Soc |
| Title: |
Membrane-proximal domain of a disintegrin and metalloprotease-17 represents the putative molecular switch of its shedding activity operated by protein-disulfide isomerase. |
| Volume: |
135 |
| Issue: |
15 |
| Pages: |
5776-81 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Killar L |
| Year: |
1999 |
| Journal: |
Ann N Y Acad Sci |
| Title: |
Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE). |
| Volume: |
878 |
|
| Pages: |
442-52 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry includes proteins with reprolysin-like metallopeptidase domains and includes ADAM10 (also known as myelin-associated metalloendopeptidase, MEROPS identifier M12.210), ADAM17 (also known as tumour necrosis factor alpha-convertase, MEROPS identifier M12.217), kuzbanian (MEROPS identifiers M12.211 and M12.322) and ADM-4 (MEROPS identifier M12.329) []. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents the membrane-proximal domain (MPD) of disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) from animals. ADAM17 is a major sheddase responsible for the regulation of a wide range of biological processes, such as cellular differentiation, regeneration, and cancer progression. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents an N-terminal helical segment of inactive rhomboid proteins (iRhom1/2), which are catalytically inactive rhomboid protease homologues that play crucial roles within the secretory pathway, including protein degradation, trafficking regulation, and inflammatory signalling []. These are metazoan specific pseudoproteases which regulate ADAM17 protease, a sheddase of the epidermal growth factor (EGF) receptor ligands and TNF, acting as trafficking factors that escort ADAM17 from the ER to the later secretory pathway. They are required for the cleavage and release of a variety of membrane-associated proteins []. iRhoms share a common structure comprising 7-helix transmembrane-spanning domains (TMDs) which is a conserved rhomboid fold (), an extended N-terminal cytosolic domain and a luminal loop [, ].These proteins have been linked to the development and progression of several autoimmune diseases including rheumatoid arthritis, lupus nephritis, as well as hemophilic arthropathy []and also in neurological disorders such as Alzheimer's and Parkinson's diseases, inflammation, cancer and skin diseases []. |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
136
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Family |
| Description: |
The Inactive Rhomboid Protein family is characterized by members that regulate the ADAM17 protease, which is responsible for shedding epidermal growth factor (EGF) receptor ligands and TNF. Although members of this family are structurally related to peptidases, they do not exhibit proteolytic activity. Instead, they modulate various physiological processes including sleep, cell survival, proliferation, migration, and inflammation. Some family members indirectly activate the EGF receptor signaling pathway, further influencing these cellular functions. |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
168
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
325
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Geesala R |
| Year: |
2019 |
| Journal: |
J Leukoc Biol |
| Title: |
Novel functions of inactive rhomboid proteins in immunity and disease. |
| Volume: |
106 |
| Issue: |
4 |
| Pages: |
823-835 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lemberg MK |
| Year: |
2016 |
| Journal: |
Semin Cell Dev Biol |
| Title: |
Inactive rhomboid proteins: New mechanisms with implications in health and disease. |
| Volume: |
60 |
|
| Pages: |
29-37 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Burzenski LM |
| Year: |
2021 |
| Journal: |
Mamm Genome |
| Title: |
Inactive rhomboid proteins RHBDF1 and RHBDF2 (iRhoms): a decade of research in murine models. |
| Volume: |
32 |
| Issue: |
6 |
| Pages: |
415-426 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
856
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
827
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
231
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Greenblatt EJ |
| Year: |
2011 |
| Journal: |
Nat Struct Mol Biol |
| Title: |
Derlin-1 is a rhomboid pseudoprotease required for the dislocation of mutant ?-1 antitrypsin from the endoplasmic reticulum. |
| Volume: |
18 |
| Issue: |
10 |
| Pages: |
1147-52 |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Homologous_superfamily |
| Description: |
This entry represents a six transmembrane helix rhomboid domain. This entry also includes derlins, inactive members of the rhomboid family of intramembrane proteases which lack an active site Ser-His dyad but retain the overall rhomboid architecture [].This domain is found in serine peptidases belonging to the MEROPS peptidase family S54 (Rhomboid, clan ST). They are integral membrane proteins related to the Drosophila melanogaster (Fruit fly) rhomboid protein . Members of this family are found in archaea, bacteria and eukaryotes.The rhomboid protease cleaves type-1 transmembrane domains usinga catalytic dyad composed of serine and histidine. The active site is embedded within the membrane and the active site residues are on different transmembrane regions. From the tertiary structure of the Escherichia coli homologue GlpG []it was shown that hydrolysis occurs in a fluid filled cavity within the membrane. Initially, a catalytic triad including a highly conserved asparagine had been proposed, but this residue has been shown not to be essential []. Drosophila rhomboid cleaves the transmembrane proteins Spitz, Gurken and Keren within their transmembrane domains to release a soluble TGFalpha-like growth factor. Cleavage occurs in the Golgi, following translocation of the substrates from the endoplasmic reticulum membrane by Star, another transmembrane protein. The growth factors are then able to activate the epidermal growth factor receptor [, ].Few substrates of mammalian rhomboid homologues have been determined, but rhomboid-like protein 2 has been shown to cleave ephrin B3 []. Parasite-encoded rhomboid enzymes are also important for invasion of host cells by Toxoplasma and the malaria parasite. Invasion of host cells first requires their recognition and this is achieved by parasite transmembrane adhesins interacting with host cell receptors. Before the parasite can enter a host cell the adhesins must be released by cleavage. In Toxoplasma rhomboid TgROM5 cleaves the adhesins, and in Plasmodium, which lacks a TgROM5 orthologue, PfROMs 1 and 4 cleave the diverse array of malaria parasite adhesins [].This entry also includes catalytically inactive rhomboid protease homologues, iRhom1/2, which are metazoan-specific and play crucial roles within the secretory pathway, including protein degradation, trafficking regulation, and inflammatory signaling []. They regulate ADAM17 protease, acting as trafficking factors that escort ADAM17 from the ER to the later secretory pathway. They are required for the cleavage and release of a variety of membrane-associated proteins [, ]. iRhombs have been linked to the development and progression of several autoimmune diseases including rheumatoid arthritis, lupus nephritis, as well as hemophilic arthropathy []and also in neurological disorders such as Alzheimer's and Parkinson's diseases, inflammation, cancer and skin diseases []. |
|
•
•
•
•
•
|
| Protein Domain |
| Type: |
Domain |
| Description: |
This entry represents a six transmembrane helix rhomboid domain.This domain is found in serine peptidases belonging to the MEROPS peptidase family S54 (Rhomboid, clan ST). They are integral membrane proteins related to the Drosophila melanogaster (Fruit fly) rhomboid protein . Members of this family are found in archaea, bacteria and eukaryotes.The rhomboid protease cleaves type-1 transmembrane domains using a catalytic dyad composed of serine and histidine. The active site is embedded within the membrane and the active site residues are on different transmembrane regions. From the tertiary structure of the Escherichia coli homologue GlpG []it was shown that hydrolysis occurs in a fluid filled cavity within the membrane. Initially, a catalytic triad including a highly conserved asparagine had been proposed, but this residue has been shown not to be essential []. Drosophila rhomboid cleaves the transmembrane proteins Spitz, Gurken and Keren within their transmembrane domains to release a soluble TGFalpha-like growth factor. Cleavage occurs in the Golgi, following translocation of the substratesfrom the endoplasmic reticulum membrane by Star, another transmembrane protein. The growth factors are then able to activate the epidermal growth factor receptor [, ].Few substrates of mammalian rhomboid homologues have been determined, but rhomboid-like protein 2 has been shown to cleave ephrin B3 []. Parasite-encoded rhomboid enzymes are also important for invasion of host cells by Toxoplasma and the malaria parasite. Invasion of host cells first requires their recognition and this is achieved by parasite transmembrane adhesins interacting with host cell receptors. Before the parasite can enter a host cell the adhesins must be released by cleavage. In Toxoplasma rhomboid TgROM5 cleaves the adhesins, and in Plasmodium, which lacks a TgROM5 orthologue, PfROMs 1 and 4 cleave the diverse array of malaria parasite adhesins [].This entry also includes catalytically inactive rhomboid protease homologues, iRhom1/2, which are metazoan-specific and play crucial roles within the secretory pathway, including protein degradation, trafficking regulation, and inflammatory signaling []. They regulate ADAM17 protease, acting as trafficking factors that escort ADAM17 from the ER to the later secretory pathway. They are required for the cleavage and release of a variety of membrane-associated proteins [, ]. iRhombs have been linked to the development and progression of several autoimmune diseases including rheumatoid arthritis, lupus nephritis, as well as hemophilic arthropathy []and also in neurological disorders such as Alzheimer's and Parkinson's diseases, inflammation, cancer and skin diseases []. |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Song WM |
| Year: |
2018 |
| Journal: |
J Exp Med |
| Title: |
Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. |
| Volume: |
215 |
| Issue: |
3 |
| Pages: |
745-760 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee HJ |
| Year: |
2021 |
| Journal: |
Biology (Basel) |
| Title: |
Idebenone Decreases A? Pathology by Modulating RAGE/Caspase-3 Signaling and the A? Degradation Enzyme NEP in a Mouse Model of AD. |
| Volume: |
10 |
| Issue: |
9 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hedges JF |
| Year: |
2022 |
| Journal: |
Front Immunol |
| Title: |
An ADAM17-Neutralizing Antibody Reduces Inflammation and Mortality While Increasing Viral Burden in a COVID-19 Mouse Model. |
| Volume: |
13 |
|
| Pages: |
918881 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hurst LA |
| Year: |
2017 |
| Journal: |
Nat Commun |
| Title: |
TNF? drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling. |
| Volume: |
8 |
|
| Pages: |
14079 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
377
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
315
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
361
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
302
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
188
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
343
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
68
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
192
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bier E |
| Year: |
1990 |
| Journal: |
Genes Dev |
| Title: |
rhomboid, a gene required for dorsoventral axis establishment and peripheral nervous system development in Drosophila melanogaster. |
| Volume: |
4 |
| Issue: |
2 |
| Pages: |
190-203 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Urban S |
| Year: |
2001 |
| Journal: |
Cell |
| Title: |
Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases. |
| Volume: |
107 |
| Issue: |
2 |
| Pages: |
173-82 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pascall JC |
| Year: |
2004 |
| Journal: |
Biochem Biophys Res Commun |
| Title: |
Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. |
| Volume: |
317 |
| Issue: |
1 |
| Pages: |
244-52 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang Y |
| Year: |
2006 |
| Journal: |
Nature |
| Title: |
Crystal structure of a rhomboid family intramembrane protease. |
| Volume: |
444 |
| Issue: |
7116 |
| Pages: |
179-80 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lemberg MK |
| Year: |
2005 |
| Journal: |
EMBO J |
| Title: |
Mechanism of intramembrane proteolysis investigated with purified rhomboid proteases. |
| Volume: |
24 |
| Issue: |
3 |
| Pages: |
464-72 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Baker RP |
| Year: |
2006 |
| Journal: |
PLoS Pathog |
| Title: |
Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria. |
| Volume: |
2 |
| Issue: |
10 |
| Pages: |
e113 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
239
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
251
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
228
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
350
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
227
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
228
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
350
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
165
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
251
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
350
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
165
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
83
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
385
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
404
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
373
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
373
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
369
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
385
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Thornton P |
| Year: |
2017 |
| Journal: |
EMBO Mol Med |
| Title: |
TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant. |
| Volume: |
9 |
| Issue: |
10 |
| Pages: |
1366-1378 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gunn TM |
| Year: |
2002 |
| Journal: |
BMC Genet |
| Title: |
Identification and preliminary characterization of mouse Adam33. |
| Volume: |
3 |
|
| Pages: |
2 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Somineni HK |
| Year: |
2014 |
| Journal: |
J Endocrinol |
| Title: |
Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice. |
| Volume: |
221 |
| Issue: |
2 |
| Pages: |
235-51 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Spin JM |
| Year: |
2011 |
| Journal: |
Physiol Genomics |
| Title: |
Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. |
| Volume: |
43 |
| Issue: |
17 |
| Pages: |
993-1003 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Raman D |
| Year: |
2011 |
| Journal: |
Toxicol Appl Pharmacol |
| Title: |
Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1?, suppress amyloid ?-induced neurotoxicity. |
| Volume: |
256 |
| Issue: |
3 |
| Pages: |
300-13 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang H |
| Year: |
2020 |
| Journal: |
Brain Res Bull |
| Title: |
IL-1R(-/-) alleviates cognitive deficits through microglial M2 polarization in AD mice. |
| Volume: |
157 |
|
| Pages: |
10-17 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dashek RJ |
| Year: |
2024 |
| Journal: |
Cell Mol Gastroenterol Hepatol |
| Title: |
Hepatocellular RECK as a Critical Regulator of Metabolic Dysfunction-associated Steatohepatitis Development. |
| Volume: |
18 |
| Issue: |
3 |
| Pages: |
101365 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mahnke K |
| Year: |
2017 |
| Journal: |
J Invest Dermatol |
| Title: |
Down-Regulation of CD62L Shedding in?T?Cells by CD39(+) Regulatory T Cells Leads?to Defective Sensitization in Contact?Hypersensitivity Reactions. |
| Volume: |
137 |
| Issue: |
1 |
| Pages: |
106-114 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gil-Bea FJ |
| Year: |
2012 |
| Journal: |
Neurobiol Dis |
| Title: |
Cholinergic denervation exacerbates amyloid pathology and induces hippocampal atrophy in Tg2576 mice. |
| Volume: |
48 |
| Issue: |
3 |
| Pages: |
439-46 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Delarasse C |
| Year: |
2011 |
| Journal: |
J Biol Chem |
| Title: |
The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein. |
| Volume: |
286 |
| Issue: |
4 |
| Pages: |
2596-606 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fiorentino L |
| Year: |
2013 |
| Journal: |
EMBO Mol Med |
| Title: |
Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. |
| Volume: |
5 |
| Issue: |
3 |
| Pages: |
441-55 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hewing NJ |
| Year: |
2013 |
| Journal: |
Invest Ophthalmol Vis Sci |
| Title: |
Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice. |
| Volume: |
54 |
| Issue: |
1 |
| Pages: |
864-70 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Meyer zu Horste G |
| Year: |
2015 |
| Journal: |
J Neuropathol Exp Neurol |
| Title: |
Neuronal ADAM10 Promotes Outgrowth of Small-Caliber Myelinated Axons in the Peripheral Nervous System. |
| Volume: |
74 |
| Issue: |
11 |
| Pages: |
1077-85 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wichert R |
| Year: |
2019 |
| Journal: |
FASEB J |
| Title: |
Meprin ? induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage. |
| Volume: |
33 |
| Issue: |
11 |
| Pages: |
11925-11940 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chodavarapu H |
| Year: |
2016 |
| Journal: |
Am J Physiol Regul Integr Comp Physiol |
| Title: |
High-fat diet-induced glucose dysregulation is independent of changes in islet ACE2 in mice. |
| Volume: |
311 |
| Issue: |
6 |
| Pages: |
R1223-R1233 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee HJ |
| Year: |
2023 |
| Journal: |
Pharmacol Res |
| Title: |
Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling. |
| Volume: |
190 |
|
| Pages: |
106725 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sundaram B |
| Year: |
2019 |
| Journal: |
Sci Signal |
| Title: |
iRhom2 inhibits bile duct obstruction-induced liver fibrosis. |
| Volume: |
12 |
| Issue: |
605 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
D?sterh?ft S |
| Year: |
2021 |
| Journal: |
Cell Mol Life Sci |
| Title: |
The iRhom homology domain is indispensable for ADAM17-mediated TNF? and EGF receptor ligand release. |
| Volume: |
78 |
| Issue: |
11 |
| Pages: |
5015-5040 |
|
•
•
•
•
•
|